Literature DB >> 23598454

HIV cure: knocking on the door.

C M Durand1, C Flexner.   

Abstract

Although major advances in drug development and public health are helping to control the HIV/AIDS epidemic, there is a strong rationale for pursuing a more definitive cure. Several bold but unproven strategies for HIV eradication are reviewed in this issue of CPT, including novel drugs, gene therapy, and bone marrow transplantation (BMT). Early results, including one probable case of HIV eradication in a leukemia patient, are intriguing but raise many questions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23598454     DOI: 10.1038/clpt.2013.22

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  6 in total

1.  Virtual screening reveals allosteric inhibitors of the Toxoplasma gondii thymidylate synthase-dihydrofolate reductase.

Authors:  Hitesh Sharma; Mark J Landau; Todd J Sullivan; Vidya P Kumar; Markus K Dahlgren; William L Jorgensen; Karen S Anderson
Journal:  Bioorg Med Chem Lett       Date:  2013-12-31       Impact factor: 2.823

2.  Discovery of potent and selective inhibitors of Toxoplasma gondii thymidylate synthase for opportunistic infections.

Authors:  Nilesh Zaware; Hitesh Sharma; Jie Yang; Ravi Kumar Vyas Devambatla; Sherry F Queener; Karen S Anderson; Aleem Gangjee
Journal:  ACS Med Chem Lett       Date:  2013-10-04       Impact factor: 4.345

3.  Bringing back the help: autologous bone marrow infusion restores CD4+ T cells in AIDS patients with chronic liver disease.

Authors:  A B Rabson
Journal:  Cell Death Dis       Date:  2013-10-10       Impact factor: 8.469

4.  Novel in situ self-assembly nanoparticles for formulating a poorly water-soluble drug in oral solid granules, improving stability, palatability, and bioavailability.

Authors:  Shujie Guo; Kevin Pham; Diana Li; Scott R Penzak; Xiaowei Dong
Journal:  Int J Nanomedicine       Date:  2016-04-07

5.  Fibrotic liver microenvironment promotes Dll4 and SDF-1-dependent T-cell lineage development.

Authors:  Zheng Gong; Bingxue Shang; Yunpeng Chu; Xiaodong Chen; Qing Li; Keli Liu; Yongjing Chen; Yin Huang; Yanyan Han; Qianwen Shang; Zhiyuan Zheng; Lin Song; Yanan Li; Rui Liu; Chenchang Xu; Xiaoren Zhang; Baochi Liu; Luowei Wang; Changshun Shao; Ying Wang; Yufang Shi
Journal:  Cell Death Dis       Date:  2019-06-05       Impact factor: 8.469

6.  HIV Testing in Urban Transgender Individuals: A Descriptive Study.

Authors:  Adrian Juarez-Cuellar; Yu-Ping Chang
Journal:  Transgend Health       Date:  2017-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.